China Cardiac Rhythm Management Devices Market Outlook to 2025

  • ID: 4516248
  • Report
  • Region: China
  • 49 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik AG
  • Boston Scientific Corp
  • Medtronic Plc
  • MORE
China Cardiac Rhythm Management Devices Market Outlook to 2025

Summary

The author's new report, "China Cardiac Rhythm Management Devices Market Outlook to 2025", provides key market data on the China Cardiac Rhythm Management Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Cardiac Rhythm Management Devices market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD), Implantable Loop Recorders (ILR) and Pacemakers.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Cardiac Rhythm Management Devices market.
  • Global corporate-level profiles of key companies operating within the China Cardiac Rhythm Management Devices market.
  • Key players covered include Medtronic plc, Abbott Laboratories, Boston Scientific Corp. and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Biotronik AG
  • Boston Scientific Corp
  • Medtronic Plc
  • MORE
1 Table of Contents

2 Introduction
2.1 What Is This Report About?
2.2 Cardiac Rhythm Management Devices Segmentation
2.3 Definitions of Markets Covered in the Report

3 Cardiac Rhythm Management Devices Market, China
3.1 Cardiac Rhythm Management Devices Market, China, Revenue ($m), 2015-2025
3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), by Segment, 2015-2025
3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), by Segment, 2015-2025
3.1.3 Pacemakers Market, China, Revenue ($m), by Segment, 2015-2025
3.2 Cardiac Rhythm Management Devices Market, China, Volume (Units), 2015-2025
3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), by Segment, 2015-2025
3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), by Segment, 2015-2025
3.2.3 Pacemakers Market, China, Volume (Units), by Segment, 2015-2025
3.3 Cardiac Rhythm Management Devices Market, China, Average Price ($), 2015-2025
3.4 Cardiac Rhythm Management Devices Market, China, Distribution Share by Revenue ($m), 2017
3.5 Cardiac Rhythm Management Devices Market, China, Company Share by Revenue ($m), 2017

4 Overview of Key Companies in China, Cardiac Rhythm Management Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Boston Scientific Corp
4.3.1 Company Overview
4.4 Biotronik AG
4.4.1 Company Overview

5 Cardiac Rhythm Management Devices Market Pipeline Products

6 Recent Developments
6.1 Corporate Communications
6.1.1 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.1.2 Sep 18, 2017: Concord Medical Announces Changes to the Board
6.1.3 Jul 24, 2017: Concord Medical Announces Changes to the Board
6.1.4 Jul 07, 2017: MPSC New COO Glendy Wang on Board
6.2 Financial Announcements
6.2.1 Sep 11, 2017: MPSC Achieves Substantial Growth in 1H 2017 Net Profit Increases 272.4% YOY
6.2.2 Aug 25, 2017: Concord Medical Reports Financial Results for the First Half of 2017
6.2.3 Aug 15, 2017: CareRay Exhibits At FIME 2017
6.2.4 Aug 11, 2017: MPSC Issues Positive Profit Alert for 2017 1H Net Profit Expected to Increase 261%
6.2.5 Mar 30, 2017: MPSC Announces 2016 Annual Results
6.3 Other Significant Developments
6.3.1 Jun 29, 2017: Concord Medical Announces Construction of Proton Treatment Building of Beijing Proton Medical Center
6.4 Product News
6.4.1 Dec 18, 2017: The CFDA Approves Impulse Dynamics’ Optimizer System for Treatment of Chronic Heart Failure in China
6.4.2 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017
6.5 Strategy And Business Planning
6.5.1 Sep 21, 2017: Concord Medical Announces Construction of Shanghai Concord Cancer Hospital

7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Distribution Share Analysis
7.1.7 Benchmarking
7.2 Consulting
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Cardiac Rhythm Management Devices Market, China, Revenue ($m), USD Constant, 2015-2020
Table 2: Cardiac Rhythm Management Devices Market, China, Revenue ($m), USD Constant, 2021-2025
Table 3: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), USD Constant, 2015-2020
Table 4: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), USD Constant, 2021-2025
Table 5: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), USD Constant, 2015-2020
Table 6: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), USD Constant, 2021-2025
Table 7: Pacemakers Market, China, Revenue ($m), USD Constant, 2015-2020
Table 8: Pacemakers Market, China, Revenue ($m), USD Constant, 2021-2025
Table 9: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2015-2020
Table 10: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2021-2025
Table 11: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2015-2020
Table 12: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2021-2025
Table 13: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2015-2020
Table 14: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2021-2025
Table 15: Pacemakers Market, China, Volume (Units), 2015-2020
Table 16: Pacemakers Market, China, Volume (Units), 2021-2025
Table 17: Cardiac Rhythm Management Devices Market, China, Average Price ($), 2015-2020
Table 18: Cardiac Rhythm Management Devices Market, China, Average Price ($), 2021-2025
Table 19: Cardiac Rhythm Management Devices Market, China, Distribution Share by Revenue ($m), USD Constant, 2017
Table 20: Cardiac Rhythm Management Devices Market, China, Company Share by Revenue ($m), USD Constant, 2017
Table 21: Cardiac Rhythm Management Devices Market Pipeline Products
Table 22: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country

List of Figures
Figure 1: Cardiac Rhythm Management Devices Market, China, Revenue ($m), USD Constant, 2015-2025
Figure 2: Cardiac Resynchronisation Therapy (CRT) Market, China, Revenue ($m), USD Constant, 2015-2025
Figure 3: Implantable Cardioverter Defibrillators (ICD) Market, China, Revenue ($m), USD Constant, 2015-2025
Figure 4: Pacemakers Market, China, Revenue ($m), USD Constant, 2015-2025
Figure 5: Cardiac Rhythm Management Devices Market, China, Volume (Units), 2015-2025
Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, China, Volume (Units), 2015-2025
Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, China, Volume (Units), 2015-2025
Figure 8: Pacemakers Market, China, Volume (Units), 2015-2025
Figure 9: Cardiac Rhythm Management Devices Market, China, Company Share (%) 2017
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Medtronic Plc
  • Abbott Laboratories
  • Boston Scientific Corp
  • Biotronik AG
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll